NCT00004827View on ClinicalTrials.gov

Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa

NACompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

March 31, 1996

Study Completion Date

June 30, 2002

Conditions

Retinitis Pigmentosa

Interventions

DRUG

docosahexaenoic acid

All Listed Sponsors

lead

Retina Foundation of the Southwest

OTHER

NCT00004827 - Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa | Biotech Hunter | Biotech Hunter